Bellerophon Therapeutics (BLPH) USPTO patents

Utility

USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19

25 May 23

The present disclosure relates to use of pulsed dose inhaled nitric oxide for treatment of infection, including infection with SARS-CoV2 and the disease state COVID-19.

Parag SHAH

Filed: 6 Apr 21

Utility

Use of Inhaled Nitric Oxide (Ino) for the Improvement of Severe Hypoxemia

25 May 23

Described are methods for improving oxygen saturation in patients suffering from hypoxemia, wherein said patients are receiving a continuous flow of oxygen at 10 L/min and exhibit an initial oxygen saturation of at least about 88%, comprising administering inhaled nitric oxide to said patients in an outpatient setting.

Parag SHAH, Deborah QUINN

Filed: 8 Aug 19

Utility

IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENT

2 Mar 23

Described are methods for reducing pulmonary resistance, reducing pulmonary pressure, and increasing pulmonary arterial compliance by providing a inhaled nitric oxide.

Parag SHAH, Peter FERNANDES

Filed: 27 Jan 21

Utility

Combination Drug Therapies of PDE-5 Inhibitors and Inhaled Nitric Oxide

31 Mar 22

Described are methods for treatment of hypertension in combination with pulsed, inhaled nitric oxide.

Parag SHAH, Peter Paul FERNANDES, Bobae KIM

Filed: 14 Jan 20

Utility

USE OF INHALED NITRIC OXIDE (iNO) FOR IMPROVING ACTIVITY LEVELS IN PATIENTS WITH LUNG-RELATED CONDITIONS

17 Mar 22

Described are methods for maintaining or improving activity levels in patients lung-related conditions.

Parag SHAH, Peter Paul FERNANDES, Bobae KIM, Martin DEKKER

Filed: 3 Jan 20

Utility

Method and Apparatus for Pulsatile Delivery of Nitric Oxide

22 Jul 21

Described are methods for providing a pulsed dose of nitric oxide during at least the first two-thirds of total inspiratory time in each single breath for a therapeutically relevant period of time.

Parag SHAH, Martin DEKKER, William LEONARD, Donatas ZUZEVICIUS

Filed: 17 May 19